mecamylamine has been researched along with sb 334867-a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berrendero, F; Flores, Á; Maldonado, R; Plaza-Zabala, A | 1 |
1 other study(ies) available for mecamylamine and sb 334867-a
Article | Year |
---|---|
Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal.
Topics: Animals; Antigens, Surface; Benzoxazoles; Intracellular Signaling Peptides and Proteins; Isoquinolines; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Microinjections; Molecular Imaging; Naphthyridines; Neuroanatomical Tract-Tracing Techniques; Neuropeptides; Orexin Receptors; Orexins; Paraventricular Hypothalamic Nucleus; Pyridines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Substance Withdrawal Syndrome; Tobacco Use Disorder; Urea | 2012 |